Table 1 Patients’ and tumor characteristics
| Â | Number | Â | Percent |
|---|---|---|---|
Median Age (range) | 49.5Â yrs. (26-77) | ||
Sex | |||
 Male | 11 |  | 42.3 |
 Female | 15 |  | 57.7 |
Diagnosis | |||
 WHO I | |||
  Pituitary adenoma | 2 | 4 | 15.4 |
  Megingioma | 1 | ||
  Craniopharyngioma | 1 | ||
 WHO II | |||
  Oligodendroglioma | 3 | 8 | 30.8 |
  Atypical meningioma | 3 | ||
  Diffuse astrocytoma | 1 | ||
  Ependymoma | 1 | ||
 WHO III | |||
  Anaplastic astrocytoma | 2 | 6 | 23.1 |
  Anaplastic oligodendroglioma | 2 | ||
  Anaplastic meningioma | 1 | ||
  Anaplastic hemangiopericytoma | 1 | ||
 WHO IV | |||
  Glioblastoma | 7 | 8 | 30.8 |
  Gliosarcoma | 1 | ||
Surgery | |||
 GTR/STR | 22 |  | 84.6 |
 Bx only/No surgery | 4 |  | 15.4 |
Concurrent Chemotherapy | 8 | Â | 30.8 |
Location | |||
 Frontal | 5 |  | 19.2 |
 Parietal | 5 |  | 19.2 |
 Temporal | 6 |  | 23.1 |
 Ocippital | 1 |  | 3.8 |
 Temporo-parietal | 2 |  | 7.7 |
 Fronto-temporal | 1 |  | 3.8 |
 Fronto-Prietal | 1 |  | 3.8 |
 Central | 5 |  | 19.2 |
Planning Target Volume (PTV) | |||
 Vol(cc) | 173.1 cm3 (30.3-493.6) | ||
 Prescribed dose | 60 Gy (40-60) | ||